Cargando…
Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants
BACKGROUND: The serial interval is the period of time between symptom onset in the primary case and symptom onset in the secondary case. Understanding the serial interval is important for determining transmission dynamics of infectious diseases like COVID-19, including the reproduction number and se...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291789/ https://www.ncbi.nlm.nih.gov/pubmed/37365505 http://dx.doi.org/10.1186/s12879-023-08407-5 |
_version_ | 1785062755421650944 |
---|---|
author | Madewell, Zachary J. Yang, Yang Longini, Ira M. Halloran, M. Elizabeth Vespignani, Alessandro Dean, Natalie E. |
author_facet | Madewell, Zachary J. Yang, Yang Longini, Ira M. Halloran, M. Elizabeth Vespignani, Alessandro Dean, Natalie E. |
author_sort | Madewell, Zachary J. |
collection | PubMed |
description | BACKGROUND: The serial interval is the period of time between symptom onset in the primary case and symptom onset in the secondary case. Understanding the serial interval is important for determining transmission dynamics of infectious diseases like COVID-19, including the reproduction number and secondary attack rates, which could influence control measures. Early meta-analyses of COVID-19 reported serial intervals of 5.2 days (95% CI: 4.9–5.5) for the original wild-type variant and 5.2 days (95% CI: 4.87–5.47) for Alpha variant. The serial interval has been shown to decrease over the course of an epidemic for other respiratory diseases, which may be due to accumulating viral mutations and implementation of more effective nonpharmaceutical interventions. We therefore aggregated the literature to estimate serial intervals for Delta and Omicron variants. METHODS: This study followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A systematic literature search was conducted of PubMed, Scopus, Cochrane Library, ScienceDirect, and preprint server medRxiv for articles published from April 4, 2021, through May 23, 2023. Search terms were: (“serial interval” or “generation time”), (“Omicron” or “Delta”), and (“SARS-CoV-2” or “COVID-19”). Meta-analyses were done for Delta and Omicron variants using a restricted maximum-likelihood estimator model with a random effect for each study. Pooled average estimates and 95% confidence intervals (95% CI) are reported. RESULTS: There were 46,648 primary/secondary case pairs included for the meta-analysis of Delta and 18,324 for Omicron. Mean serial interval for included studies ranged from 2.3–5.8 days for Delta and 2.1–4.8 days for Omicron. The pooled mean serial interval for Delta was 3.9 days (95% CI: 3.4–4.3) (20 studies) and Omicron was 3.2 days (95% CI: 2.9–3.5) (20 studies). Mean estimated serial interval for BA.1 was 3.3 days (95% CI: 2.8–3.7) (11 studies), BA.2 was 2.9 days (95% CI: 2.7–3.1) (six studies), and BA.5 was 2.3 days (95% CI: 1.6–3.1) (three studies). CONCLUSIONS: Serial interval estimates for Delta and Omicron were shorter than ancestral SARS-CoV-2 variants. More recent Omicron subvariants had even shorter serial intervals suggesting serial intervals may be shortening over time. This suggests more rapid transmission from one generation of cases to the next, consistent with the observed faster growth dynamic of these variants compared to their ancestors. Additional changes to the serial interval may occur as SARS-CoV-2 continues to circulate and evolve. Changes to population immunity (due to infection and/or vaccination) may further modify it. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08407-5. |
format | Online Article Text |
id | pubmed-10291789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102917892023-06-27 Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants Madewell, Zachary J. Yang, Yang Longini, Ira M. Halloran, M. Elizabeth Vespignani, Alessandro Dean, Natalie E. BMC Infect Dis Research BACKGROUND: The serial interval is the period of time between symptom onset in the primary case and symptom onset in the secondary case. Understanding the serial interval is important for determining transmission dynamics of infectious diseases like COVID-19, including the reproduction number and secondary attack rates, which could influence control measures. Early meta-analyses of COVID-19 reported serial intervals of 5.2 days (95% CI: 4.9–5.5) for the original wild-type variant and 5.2 days (95% CI: 4.87–5.47) for Alpha variant. The serial interval has been shown to decrease over the course of an epidemic for other respiratory diseases, which may be due to accumulating viral mutations and implementation of more effective nonpharmaceutical interventions. We therefore aggregated the literature to estimate serial intervals for Delta and Omicron variants. METHODS: This study followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A systematic literature search was conducted of PubMed, Scopus, Cochrane Library, ScienceDirect, and preprint server medRxiv for articles published from April 4, 2021, through May 23, 2023. Search terms were: (“serial interval” or “generation time”), (“Omicron” or “Delta”), and (“SARS-CoV-2” or “COVID-19”). Meta-analyses were done for Delta and Omicron variants using a restricted maximum-likelihood estimator model with a random effect for each study. Pooled average estimates and 95% confidence intervals (95% CI) are reported. RESULTS: There were 46,648 primary/secondary case pairs included for the meta-analysis of Delta and 18,324 for Omicron. Mean serial interval for included studies ranged from 2.3–5.8 days for Delta and 2.1–4.8 days for Omicron. The pooled mean serial interval for Delta was 3.9 days (95% CI: 3.4–4.3) (20 studies) and Omicron was 3.2 days (95% CI: 2.9–3.5) (20 studies). Mean estimated serial interval for BA.1 was 3.3 days (95% CI: 2.8–3.7) (11 studies), BA.2 was 2.9 days (95% CI: 2.7–3.1) (six studies), and BA.5 was 2.3 days (95% CI: 1.6–3.1) (three studies). CONCLUSIONS: Serial interval estimates for Delta and Omicron were shorter than ancestral SARS-CoV-2 variants. More recent Omicron subvariants had even shorter serial intervals suggesting serial intervals may be shortening over time. This suggests more rapid transmission from one generation of cases to the next, consistent with the observed faster growth dynamic of these variants compared to their ancestors. Additional changes to the serial interval may occur as SARS-CoV-2 continues to circulate and evolve. Changes to population immunity (due to infection and/or vaccination) may further modify it. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08407-5. BioMed Central 2023-06-26 /pmc/articles/PMC10291789/ /pubmed/37365505 http://dx.doi.org/10.1186/s12879-023-08407-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Madewell, Zachary J. Yang, Yang Longini, Ira M. Halloran, M. Elizabeth Vespignani, Alessandro Dean, Natalie E. Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants |
title | Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants |
title_full | Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants |
title_fullStr | Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants |
title_full_unstemmed | Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants |
title_short | Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants |
title_sort | rapid review and meta-analysis of serial intervals for sars-cov-2 delta and omicron variants |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291789/ https://www.ncbi.nlm.nih.gov/pubmed/37365505 http://dx.doi.org/10.1186/s12879-023-08407-5 |
work_keys_str_mv | AT madewellzacharyj rapidreviewandmetaanalysisofserialintervalsforsarscov2deltaandomicronvariants AT yangyang rapidreviewandmetaanalysisofserialintervalsforsarscov2deltaandomicronvariants AT longiniiram rapidreviewandmetaanalysisofserialintervalsforsarscov2deltaandomicronvariants AT halloranmelizabeth rapidreviewandmetaanalysisofserialintervalsforsarscov2deltaandomicronvariants AT vespignanialessandro rapidreviewandmetaanalysisofserialintervalsforsarscov2deltaandomicronvariants AT deannataliee rapidreviewandmetaanalysisofserialintervalsforsarscov2deltaandomicronvariants |